ABSTRACT
INTRODUCTION
Signal peptide sequences are required for proper orientation of the amino terminal of mature secreted proteins and type I membrane proteins inside the endoplasmic reticulum and exocytotic vesicles. The signal sequence trap (SST) (6) takes advantage of the presence of these signal sequences for the selective cloning of new members of these proteins without the use of biological functional assays. Several strategies have been reported (3, 8, 10) and usually use an expression vector containing a membrane-anchored protein, such as the IL-2 α receptor (8, 10) or CD4 (3), devoid of its signal sequence. The 5 ′ terminal ends of cDNAs, approximately 400 bp in length, are randomly cloned into these expression vectors. Inserts with signal sequences cloned in-frame with the correct orientation resulted in expression of fusion proteins on plasma membranes of transfected cells. They were detected by flow cytometry with specific antibodies to the membrane-anchored proteins used in the vector (3, 8, 10) .
Using this method, large-scale screening of clones from an SST cDNA library may be possible (8) . Usually, methods based on flow cytometry involve transfecting a large number of clones into target cells, followed by repeated sorting for positive cells that express the surface tag. The plasmid is subsequently rescued from the sorted cells and characterized. We have devised a simpler and alternative method for SST. This involves the cloning of 5 ′ terminal cDNA ends upstream to the human immunodeficiency virus (HIV-1) p24 cDNA in an expression vector. Chimeric proteins bearing 5 ′ terminal signal sequences cloned in-frame to p24 will be secreted into the cell culture of transfected cells and can be measured with an ELISA kit for the HIV-1 p24 antigen. In this way, large pools of recombinant clones may be easily subjected to highthroughput screening in a 96-well plate format for novel secreted proteins.
MATERIALS AND METHODS

Cell Lines
The human epitheloid cervical carcinoma cell line, HeLa, and the human embryonic kidney cell line, 293, bearing the large T antigen from SV40 (293T) were purchased from ATCC (Manassas, VA, USA) and cultured at 37°C in 5% CO 2 in EMEM containing 2 mM L-glutamine, 1.5 g/L sodium bicarbonate, 0.1 mM nonessential amino acids, 1 mM sodium pyruvate and 10% fetal bovine serum.
Plasmids and Constructs
The HIV-1 p24 cDNA was amplified by PCR (94°C for 1 min, 62°C for 1 min and 68°C for 1 min) from the plasmid pHXB2gpt (9) with P24FOR, 5 ′ -GGCC -TCGAGCCTATAGTGCAGAACATC -CAG-3 ′ and P24REV , 5 ′ -GGCTCTAG-ATTATTGTGACGAGGGGTCGTT-3 ′ . The HXB2 Pr41 gag protein was amplified with P17FOR, 5 ′ -GGCCTCGAGA -GAATGGGTGCGAGAGCGTC-3 ′ and P24REV. PCR products were digested with Xho I and Xba I and cloned into the pcDNA3.1(+) vector from Invitrogen (Carlsbad, CA, USA) to generate pCMV-P24 and pCMV-P17P24, respectively. The 5 ′fusion of the human RANTES and CD4 signal sequences to the p24 DNA was carried out using a two-step "megaprimer" method for sitedirected mutagenesis (6) . The 5 ′ terminal region of the human RANTES cDNA (7) (nucleotides 27-95) was amplified using primers RANFOR, 5 ′ -GCGAATTCACCATGAAGGTCTCC -GCGG-3 ′ and RANP24REV, 5 ′ -GTTC -TGCACTATAGGTGGGGAGGCAG-ATGCA-3 ′ (p24 nucleo-tides are underlined) at 94°C for 1 min, 52°C for 1 min and 68°C for 1 min with a RANTES expression vector as template.
The resultant PCR product and pCMV-P24 were used as templates in a second round of PCR (94°C for 1 min, 62°C for 1 min and 68°C for 1 min) with the primers RANFOR and P24 -REV. To generate the chimeric CD4-p24 product, the 5 ′ terminal region of the human CD4 cDNA (4) (nucleotides 76-160) was similarly amplified with CD4FOR, 5 ′ -GCGAATTCACAATG-AACCGGGGAGTCCC-3 ′ and CD4 -P24REV, 5 ′ -GTTCTGCACTATAGGT -TTCTTTCCCTGAGTGG-3 ′ (p24 nucleotides are underlined) using an expression plasmid for a human CD4 as template. The PCR product and pCMV-P24 were used as templates in a second round of PCR with primers CD4FOR and P24REV. The 1.18 kb PCR products were digested with Eco RI and Xba I and cloned into pcDNA3.1(+) to generate pCMV-RANSSP24 and pCMV-CD4SSP24, respectively.
DNA Sequencing
DNA sequencing on all constructs created was carried out in the Biopolymer Sequencing Facility at the University of Maryland at Baltimore, using the TaqDyeDeoxy ™Terminator Cycle Sequencing Kit and the automated Model 377 DNA Sequencer from PE Biosystems (Foster City, CA, USA).
Cell Transfections
Transfection experiments were performed using SuperFect ™Transfection Reagent from Qiagen (Valencia, CA, USA), according to the manufacturer's protocol. Briefly, 1.5 ×10 5 HeLa or 293T cells were plated into 6-well tissue culture plates and exposed to a mixture of 5 µ g of plasmid and 75 µ g SuperFect in 150 µ L serum-free EMEM for 3 h at 37°C and 5% CO 2 . After this step, the cells were washed and added with fresh complete media. At the indicated times, an aliquot of cell media was harvested for p24 ELISA analysis. Where less than 5 µ g of DNA were used for transfection, the amounts of SuperFect and serum-free media used were scaled down according to the manufacturer's recommendations.
Flow Cytometry
The 293T cells were harvested two days posttransfection, washed in PBS and resuspended at 1 × 10 6 cells/mL. Then, 0.5 mL of cells were incubated with an anti-human CD4 antibody or an isotype-matched control from Sigma (St. Louis, MO, USA) for 30 min at 4°C, washed and re-incubated with a goat anti-mouse IgG antibody conjugated with phycoerythrin (Sigma). Cells were washed as before and analyzed on a FACScalibur ™Flow Cytometer (Becton Dickinson, San Jose, CA, USA). Live cells were gated, and a total of 2 0 000 events were collected per analysis.
p24 ELISA
p24 ELISAs were performed at the core facility at the Institute of Human Virology (University of Maryland at Baltimore) using a p24 ELISA Kit ™ from R & D Systems (Minneapolis, MN, USA), following the manufacturer's instructions. In all experiments, standards were simultaneously assayed over a range from 6.25-400 pg/mL.
RESULTS AND DISCUSSION
Release of P24 Antigen in Tissue Culture Supernatants When Coupled With Heterologous Signal Peptides
The constructs pCMV-P24, pCMV-P17P24, pCMV-RANSSP24 and pCMV-CD4SSP24, expressing HIV-1 p24, p41, p24 with a RANTES or a CD4 signal peptide, respectively, and the vector pCDNA3.1(+) were separately transfected into 1 ×10 5 HeLa and 293T cell lines using SuperFect. At days 2, 3 and 5 posttransfection, 500 µ L of culture media were removed and assayed for secreted p24 antigen using a commercial ELISA kit. As expected, media harvested from cells transfected pCMV-P24 did not contain detectable levels of p24 antigen (data not shown), because the p24 cDNA in this construct does not encode any signal peptide at its 5 ′ end to facilitate its extracellular release. Interestingly, transfection of the construct pCMV-P17P24 also did not give detectable levels of p24 antigen in the cell media (data not shown). This was unexpected as it has been previously demonstrated that the first 10 amino acids of the Pr55 gag polyprotein alone was sufficient to provide a secretory signal for release of viral particles (1, 5 et al. indicates that in the absence of the HIV protease or of other gag components such as the C terminal peptide, p16, the Pr41 gag polyprotein may not be efficiently released into the cell media (2) and may explain why we failed to observe secretion of the HIV-1 gag protein from our pCMV-P17P24 construct. However, chimeric p24 antigens were readily detected in both HeLa and 293T cells after transfection with pCMV-RANSSP24 ( Figure 1A ) and pCMV-CD4SSP24 ( Figure 1B) . The p24 levels present in the cell media also increased in a dose-dependent manner with 2 and 5 µ g of plasmid DNA transfected into the cell lines (Figure 1 ). In addition, culture media harvested from all transfectants exhibited a steady increase in the levels of p24 antigen from days 2-5 ( Figure 1) .
When the amount of transfected plasmid DNA was decreased to 0.5 µ g, p24 was still detectable in tissue culture supernatants of both HeLa and 293T cell lines (data not shown). It should be noted that we did not alter the codon usage of the p24, which is not optimal for expression in mammalian cells. We anticipate that optimizing codon usage should result in higher gene expression and further improve the detection of proteins fused with p24.
High Sensitivity of the p24-Based Detection System is Highly Sensitive
To determine the sensitivity of our cloning system, we carried out a series of dilution experiments in which pCMV-SSRANP24 or pCMV-CD4P24 was transfected together with the vector pcDNA3.1 (+) into 293T cells. Ratios ranged from 5:0-1:100, with the total amount of DNA transfected kept at 5 µ g in all cases. Transfection of 5 µ g of pcDNA3.1(+) did not produce any detectable p24 antigens ( Figure 2C ). As we observed previously, transfection of 5 µ g of chimeric p24 constructs (or a ratio of 5:0) produced high levels of p24 antigens in the culture media (Figure 2A) . Transfection of the p24 expression plasmids and pcDNA3.1(+) at a ratio of 1:1 readily yielded detectable levels of p24 (Figure 2A ). When the ratios of the chimeric p24 expression constructs to pcDNA3.1(+) were progressively decreased to 1:5, 1:10, 1:50 and 1:100 (equivalent to 0.5, 0.1 and 0.05 µ g of p24 expression plasmids respectively), p24 antigens continued to be released into the culture supernatants, in a dose-dependent fashion (Figure 2, B and C) . In all cases, release of p24 in the tissue culture supernatant increased with time (Figure 2, A-C) .
The cut-off for detection occurred at the dilution ratio of 1:100, as further lower dilution ratios such as 1:150 and 1:200 did not produce detectable p24 signals (data not shown).
To compare the sensitivity of our assay with the conventional method by FACS analysis, we co-transfected 293T cells with a human CD4 expression construct and pcDNA3.1(+) at similar ratios as above. Two days after transfection, cells were harvested and analyzed for the expression of CD4 receptors by flow cytometry. Cells transfected with pcDNA3.1(+) alone did not express CD4 markers (Figure 3, panel  B) . Positive staining for CD4 receptors was observed when cells were transfected at ratios of 5:0-1:100 (Figure 3 , panels C-H). Transfection at ratios lower than 1:100 also yielded marginal levels of surface CD4 markers that were barely detectable by flow cytometry ( Figure 3 , panels I and J). Thus, the sensitivity of the signal sequence trapping method we describe here is at least comparable to the conventional method by flow cytometry. Methods to isolate secreted proteins based on the SST have been described (3,6,8,10 ), but they have some disadvantages: (a) membrane-bound markers are used, and their detection is based on flow cytometry-based techniques, which is time consuming and expensive and (b) cellular proteins are used as markers, thus raising the possibility of a background signal caused by cellular expression of the wild-type marker. By using our method of detection, the process of screening large libraries can be made simpler, quicker
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Vol. 28, No. 1 (2000) BioTechniques 129 and less labor intensive because the secreted viral antigen can be detected by a standard, commercially available ELISA test. The use of a viral antigen is less likely to produce a background noise that could interfere with detection. Although it may be possible to use transfected cells in ELISAs, the experimental procedures for recovery of viable cells will be more difficult and may produce a higher background. Our method for signal peptide trapping using the HIV-1 p24 antigen is highly sensitive. As we have demonstrated, as little as 0.05 µ g of a positive expression construct or when the construct is present at a ratio 1:100 in a mixed pool readily yields a detectable signal two days after transfection. We expect that optimizing the codon usage of the viral protein marker will further enhance the sensitivity of detection. Solutions containing the radioactive salts, sodium iodide Na 125 I and Na 131 I, are commonly used to label tyrosine and histidine residues on proteins and peptides (3) . The resulting labeled molecules, although radioactive and requiring appropriate handling precautions, are relatively safe to handle. On the other hand, labeling requires reagents and creates waste solutions, which contain free iodine. These liquids are more hazardous (1, 2) .
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Waste that contains free iodide poses several risks: (i) Being a liquid, spills can result from handling or compromised containers; (ii)Free iodine, which is continuously generated through the oxidation of iodide, is highly reactive and can become incorporated into surfaces that it contacts, which makes effective decontamination difficult; and (iii) Once generated, free iodine has an appreciable vapor pressure and, as a radioactive gas, poses a significant contamination hazard to personnel and radiation-sensitive equipment such as scintillation counters.
A waste receptacle that dramatically reduces these risks can be easily assembled from a 50 mL conical bottom tube, a tightly packed cotton plug or tampon and a small quantity of glycerol, disodium phosphate and activated charcoal. The tampon is dipped into a mixture consisting of 10 parts glycerol, 3 parts charcoal and one part disodium phosphate and then placed into the conical bottom tube. The tube can then be used as a waste receptacle for up to 18 mL of liquid waste and up to 20 pipet tips.
The cotton plug quickly absorbs and immobilizes liquid waste, reducing the risk of a spill; the disodium phosphate slows the acid-catalyzed creation of free iodine, the reduced levels of free iodine are absorbed by the charcoal and the glycerol eliminates the risk of creating radioactive dust, should the container become damaged and the contents be allowed to dry.
To test the effectiveness of this device in reducing the liberation of iodine gas, iodine levels in the headspace of the device were measured for 24 h following the introduction of Na 125 I in solution. Therefore, 50 mL conical bottom tubes were prepared as described above, while the control tubes were left empty. To each tube, we added 10 mL of a solution containing 20 mM sodium acetate, pH 5.0 and 200 µ Ci of Na 125 I. Next, we packed a pipet tip with an aerosol guard with 120 mg of activated charcoal and suspended it in the head space of each tube using a paper clip.
